Clinicopathological features and treatment analysis in male breast cancer
10.3760/cma.j.issn.0254-9026.2015.07.026
- VernacularTitle:男性乳腺癌患者临床病理特征及诊治分析
- Author:
Jiafang MA
;
Yu QIAO
;
Li DING
;
Yongqiang ZHANG
;
Budong ZHU
- Publication Type:Journal Article
- Keywords:
Breast neoplasms,male;
Pathology,clinical
- From:
Chinese Journal of Geriatrics
2015;34(7):790-792
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinicopathological features,diagnosis and treatment experience,in order to improve the recognition of male breast cancer and prepare for the study of standardized treatment of breast cancer.Methods Data of epidemiological characteristics,clinical and pathological parameters,treatment and outcome from 43 male breast cancer patients were collected and analyzed in Peking University Cancer Hospital and Beijing Hospital from January 2009 to December 2014.Results Of these patients,42 (97.6％) cases presented with located tumors,11 (25.5％) cases were on pathological stage Ⅲ or stage Ⅳ,and 40 (93.0％) cases were with hormone receptor positive breast cancer and 3 (6.9％) cases were with human epidermal growth factor receptors (HER)-2 positive breast cancer.Patients were stratified according to more or less than 70 years of age,and there were no significant differences in clinicopathological features between the two year groups.But 3 cases with HER-2 over-expressed were all less than 70 years old.38 (88.4％) patients underwent surgical treatment,among which 32 HR-positive patients (74.4％) received tamoxifen as adjuvant endocrine therapy.The median follow-up periods was 31 months (6.1-55.4 months),7 (16.3％) patients developed local recurrence or distant metastasis.Conclusions Male breast cancer is often diagnosed at a later stage and has inferior outcome.Majority of male breast cancer are found to be HR positive,hence hormonal therapy should be strongly considered.
